Multiple Sclerosis
Are you or a loved one living with multiple sclerosis?
A new clinical study may be an option. In this study, our doctors are evaluating the effects of an investigational medication compared to placebo in delaying disability progression in non-relapsing secondary progressive multiple sclerosis (nrSPMS).
We’re seeking the following people to take part:
- Aged 18 to 60
- Previous diagnosis of RRMS
- Current diagnosis of SPMS
- Documented evidence of disability progression observed during the 12 months before screening
- Absence of clinical relapses for at least 24 months
Those who qualify for the study will receive all study-related care at no cost, no health insurance is needed.
May receive compensation for time and travel.
